Cash flow Pidilite Industries Limited

Equities

PIDILITIND

INE318A01026

Diversified Chemicals

Market Closed - NSE India S.E. Other stock markets 12:49:42 11/07/2025 BST			5-day change	1st Jan Change
3,000.80 ^INR	-2.10%		-2.58%	+3.32%

05-12	Jefferies Adjusts Pidilite Industries' Price Target to INR3,270 from INR3,040, Keeps at Hold	MT
05-09	Pidilite Industries Limited, Q4 2025 Earnings Call, May 09, 2025

8ea179f9c441e3f41a3c7b29.F8nvWSRX8pkTvTV4SoXkRVeFKZN3PwOJRF91it_LqUg.fv3dI0MRpNJejRhAJdWABxrCXqIdfnu7EBMAwa6z0yNBkYo9QWLf13XRdA

Published financial data: PIDILITE INDUSTRIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	72.94B	72.93B	99.21B	118B	124B
Total Revenues	72.94B	72.93B	99.21B	118B	124B
Cost of Goods Sold, Total	34.43B	34.11B	55.09B	68.23B	60.63B
Gross Profit	38.52B	38.81B	44.12B	49.76B	63.2B
Selling General & Admin Expenses, Total	12.32B	11.62B	13.33B	15.62B	19.71B
Provision for Bad Debts	-	-	-	-	-
Depreciation & Amortization - (IS)	1.7B	2.01B	2.4B	2.7B	3.41B
Other Operating Expenses	10.39B	10.3B	12.02B	13.93B	16.3B
Other Operating Expenses, Total	24.42B	23.93B	27.74B	32.25B	39.42B
Operating Income	14.1B	14.88B	16.39B	17.51B	23.78B
Interest Expense, Total	-336M	-372M	-421M	-476M	-512M
Interest And Investment Income	240M	180M	58M	88.4M	124M
Net Interest Expenses	-95.5M	-193M	-363M	-388M	-388M
Income (Loss) On Equity Invest.	30.3M	39.8M	119M	66.4M	-40.5M
Currency Exchange Gains (Loss)	-41.3M	-23.7M	-217M	-342M	-65.1M
Other Non Operating Income (Expenses)	1.21B	134M	59.9M	178M	242M
EBT, Excl. Unusual Items	15.2B	14.84B	15.98B	17.02B	23.53B
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	403M	119M	189M	912M
Gain (Loss) On Sale Of Assets	26.7M	-57.3M	-91.2M	5.5M	-52.3M
Asset Writedown	-552M	-	-	-	-
Insurance Settlements	4.6M	74.7M	32.9M	14.1M	66.7M
Other Unusual Items	15.9M	-33M	92.9M	3.9M	-665M
EBT, Incl. Unusual Items	14.7B	15.22B	16.14B	17.23B	23.79B
Income Tax Expense	3.48B	3.96B	4.07B	4.34B	6.32B
Earnings From Continuing Operations	11.22B	11.26B	12.07B	12.89B	17.47B
Net Income to Company	11.22B	11.26B	12.07B	12.89B	17.47B
Minority Interest	-56.3M	50.8M	8M	-156M	-180M
Net Income - (IS)	11.16B	11.31B	12.08B	12.73B	17.29B
Net Income to Common Incl Extra Items	11.16B	11.31B	12.08B	12.73B	17.29B
Net Income to Common Excl. Extra Items	11.16B	11.31B	12.08B	12.73B	17.29B
Per Share Items
Net EPS - Basic	21.98	22.26	23.76	25.05	34.01
Basic EPS - Continuing Operations	21.98	22.26	23.76	25.05	34.01
Basic Weighted Average Shares Outstanding	508M	508M	508M	508M	508M
Net EPS - Diluted	21.97	22.24	23.75	25.03	33.98
Diluted EPS - Continuing Operations	21.97	22.24	23.75	25.03	33.98
Diluted Weighted Average Shares Outstanding	508M	509M	509M	509M	509M
Normalized Basic EPS	18.59	18.35	19.67	20.62	28.57
Normalized Diluted EPS	18.59	18.34	19.66	20.61	28.54
Dividend Per Share	7	8.5	10	11	16
Payout Ratio	73.93	0.06	35.76	39.92	32.37
Supplemental Items
EBITDA	15.44B	16.49B	18.32B	19.62B	26.27B
EBITA	14.26B	15.09B	16.68B	17.84B	24.09B
EBIT	14.1B	14.88B	16.39B	17.51B	23.78B
EBITDAR	15.64B	16.71B	18.57B	19.98B	26.72B
Total Revenues (As Reported)	74.44B	73.72B	99.57B	118B	125B
Effective Tax Rate - (Ratio)	23.66	26.03	25.22	25.21	26.56
Total Current Taxes	3.84B	4B	4.08B	4.38B	6.39B
Total Deferred Taxes	-363M	-35.2M	-9.2M	-38M	-67M
Normalized Net Income	9.45B	9.32B	10B	10.48B	14.53B
Interest on Long-Term Debt	82.1M	79.1M	89.2M	131M	175M
Non-Cash Pension Expense	600K	-1.1M	-700K	10.4M	-24.1M
Supplemental Operating Expense Items
Advertising Expense	2.85B	1.6B	1.96B	2.8B	4.6B
Selling and Marketing Expenses	2.85B	1.6B	1.96B	2.8B	4.6B
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	765M	726M	716M	843M	916M
Net Rental Expense, Total	204M	217M	246M	364M	454M
Imputed Operating Lease Interest Expense	273M	209M	222M	344M	481M
Imputed Operating Lease Depreciation	-69.71M	8.06M	24.25M	19.97M	-27.01M
Maintenance & Repair Expenses, Total	402M	347M	644M	637M	687M
Stock-Based Comp., SG&A Exp. (Total)	144M	172M	281M	141M	90.7M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	144M	172M	281M	141M	90.7M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	6.92B	4.43B	3.52B	3.1B	5.15B
Short Term Investments	66.3M	62.1M	1.4M	141M	161M
Trading Asset Securities, Total	7.2B	1.76B	1.74B	5.31B	18.7B
Total Cash And Short Term Investments	14.19B	6.25B	5.26B	8.55B	24.01B
Accounts Receivable, Total	11.77B	13.93B	15.02B	16.04B	17.45B
Other Receivables	158M	125M	117M	68.3M	97.6M
Notes Receivable	174M	169M	172M	273M	342M
Total Receivables	12.1B	14.23B	15.31B	16.38B	17.89B
Inventory	9.29B	12.34B	16.95B	18.17B	14.15B
Prepaid Expenses	143M	141M	256M	254M	247M
Restricted Cash	1.4M	400K	800K	500K	1.4M
Other Current Assets, Total	1.89B	2.19B	2.39B	2.26B	2.07B
Total Current Assets	37.61B	35.15B	40.16B	45.62B	58.36B
Gross Property Plant And Equipment	26.74B	30.03B	34.08B	40.2B	44.39B
Accumulated Depreciation	-11.26B	-12.66B	-14.24B	-16.13B	-17.36B
Net Property Plant And Equipment	15.48B	17.37B	19.83B	24.07B	27.03B
Long-term Investments	4.7B	3.49B	2.95B	3.5B	3.65B
Goodwill	1.84B	12.84B	12.87B	12.9B	12.82B
Other Intangibles, Total	3.34B	16.91B	16.59B	16.24B	16.14B
Accounts Receivable Long-Term	200M	238M	299M	274M	282M
Loans Receivable Long-Term	40.9M	48.5M	50.5M	62M	77.5M
Deferred Tax Assets Long-Term	130M	166M	213M	202M	283M
Other Long-Term Assets, Total	2.02B	2.09B	2.2B	2.39B	2.4B
Total Assets	65.36B	88.3B	95.16B	105B	121B
Liabilities
Accounts Payable, Total	6.21B	10.07B	10.49B	10.64B	11.48B
Accrued Expenses, Total	4.42B	5.76B	6.35B	7.38B	8.91B
Short-term Borrowings	1.44B	2.02B	2.84B	1.63B	1.31B
Current Portion of Long-Term Debt	71M	87.1M	12.5M	-	-
Current Portion of Leases	284M	277M	324M	517M	575M
Current Income Taxes Payable	86.7M	250M	137M	438M	283M
Unearned Revenue Current, Total	1.24B	1.34B	1.56B	1.97B	2.33B
Other Current Liabilities	2.4B	4.55B	1.53B	1.53B	3.08B
Total Current Liabilities	16.15B	24.35B	23.25B	24.11B	27.98B
Long-Term Debt	251M	124M	17.2M	-	-
Long-Term Leases	831M	807M	960M	1.76B	1.94B
Pension & Other Post Retirement Benefits	114M	133M	154M	160M	304M
Deferred Tax Liability Non Current	823M	3.98B	3.98B	3.98B	3.92B
Other Non Current Liabilities	478M	583M	764M	787M	727M
Total Liabilities	18.64B	29.97B	29.13B	30.79B	34.87B
Common Stock, Total	508M	508M	508M	508M	509M
Additional Paid In Capital	232M	260M	465M	500M	929M
Retained Earnings	43.4B	54.7B	62.64B	70.31B	81.52B
Comprehensive Income and Other	417M	457M	421M	806M	1.12B
Total Common Equity	44.56B	55.93B	64.04B	72.12B	84.07B
Minority Interest	2.16B	2.4B	1.99B	2.34B	2.1B
Total Equity	46.71B	58.33B	66.03B	74.46B	86.17B
Total Liabilities And Equity	65.36B	88.3B	95.16B	105B	121B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	508M	508M	508M	508M	509M
ECS Total Common Shares Outstanding	508M	508M	508M	508M	509M
Book Value / Share	87.69	110.06	125.99	141.89	165.3
Tangible Book Value	39.38B	26.18B	34.58B	42.99B	55.11B
Tangible Book Value Per Share	77.5	51.52	68.04	84.57	108.35
Total Debt	2.88B	3.31B	4.16B	3.91B	3.82B
Net Debt	-11.31B	-2.94B	-1.1B	-4.64B	-20.19B
Debt Equivalent of Unfunded Proj. Benefit Obligation	67.1M	88.9M	256M	266M	431M
Debt Equivalent Oper. Leases	1.63B	1.73B	1.97B	2.92B	3.63B
Minority Interest, Total (Incl. Fin. Div)	2.16B	2.4B	1.99B	2.34B	2.1B
Equity Method Investments, Total	253M	325M	607M	950M	1.05B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	4.2B	5.98B	8.13B	8.71B	5.99B
Inventories - Work In Process, Total	788M	950M	1.34B	1.27B	1.17B
Inventories - Finished Goods, Total	4.24B	5.32B	7.38B	8.07B	6.91B
Inventories - Others	63.6M	88M	104M	122M	84.3M
Land - (BS)	1.1B	1.13B	1.14B	1.12B	1.11B
Buildings, Total	4.67B	5.35B	6.32B	7.22B	10.3B
Machinery, Total	16.14B	17.85B	20.62B	22.39B	24.74B
Full Time Employees	6.06K	6.38K	7.62K	7.31K	7.91K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Assets on Operating Lease - Gross	451M	500M	749M	809M	1.05B
Assets on Operating Lease - Accumulated Depreciation	-90.3M	-102M	-166M	-190M	-166M
Accumulated Allowance for Doubtful Accounts (Supple)	790M	938M	1.09B	1.12B	1.12B

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	11.16B	11.31B	12.08B	12.73B	17.29B
Depreciation & Amortization - CF	1.5B	1.75B	2.05B	2.3B	2.84B
Amortization of Goodwill and Intangible Assets - (CF)	153M	208M	294M	334M	310M
Depreciation & Amortization, Total	1.65B	1.96B	2.34B	2.64B	3.15B
Amortization of Deferred Charges, Total - (CF)	48.7M	46.1M	56.9M	61.5M	57.3M
(Gain) Loss From Sale Of Asset	-26.7M	57.3M	91.2M	-5.5M	256M
(Gain) Loss on Sale of Investments - (CF)	-1.1B	-366M	-119M	-189M	-912M
Asset Writedown & Restructuring Costs	552M	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-30.3M	-39.8M	-119M	-66.4M	40.5M
Stock-Based Compensation (CF)	144M	172M	281M	141M	90.7M
Provision and Write-off of Bad Debts	84.5M	110M	167M	69.1M	29.5M
Other Operating Activities, Total	-259M	402M	-116M	982M	1.5B
Change In Accounts Receivable	-376M	-1.76B	-1.23B	-838M	-1.44B
Change In Inventories	200K	-2.79B	-4.6B	-1.43B	3.89B
Change In Accounts Payable	417M	3.55B	760M	316M	1.03B
Change in Other Net Operating Assets	524M	1.27B	-34.4M	1.17B	2.26B
Cash from Operations	12.8B	13.92B	9.55B	15.58B	27.24B
Capital Expenditure	-4.67B	-3.54B	-3.75B	-5.05B	-5.59B
Sale of Property, Plant, and Equipment	232M	17.6M	7.7M	76.3M	57.6M
Cash Acquisitions	-	-20.57B	-2.62B	-	-
Divestitures	-	-	-	-	472M
Investment in Marketable and Equity Securities, Total	5.24B	7.02B	724M	-4.07B	-12.69B
Other Investing Activities, Total	225M	189M	56.8M	62.6M	52.6M
Cash from Investing	1.03B	-16.88B	-5.58B	-8.99B	-17.69B
Short Term Debt Issued, Total	108M	279M	1.03B	-	-
Long-Term Debt Issued, Total	220M	-	-	-	-
Total Debt Issued	328M	279M	1.03B	-	-
Short Term Debt Repaid, Total	-	-	-	-776M	-130M
Long-Term Debt Repaid, Total	-340M	-451M	-668M	-521M	-819M
Total Debt Repaid	-340M	-451M	-668M	-1.3B	-948M
Issuance of Common Stock	100K	100K	100K	-	300K
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-8.25B	-6.9M	-4.32B	-5.08B	-5.6B
Common & Preferred Stock Dividends Paid	-8.25B	-6.9M	-4.32B	-5.08B	-5.6B
Other Financing Activities, Total	-226M	-584M	-720M	-184M	-879M
Cash from Financing	-8.49B	-762M	-4.68B	-6.56B	-7.42B
Net Change in Cash	5.33B	-3.72B	-707M	21.9M	2.12B
Supplemental Items
Cash Interest Paid	254M	293M	332M	345M	370M
Cash Income Tax Paid (Refund)	3.93B	3.71B	4.62B	4.12B	6.48B
Levered Free Cash Flow	7.19B	9.85B	1.01B	8.15B	19.1B
Unlevered Free Cash Flow	7.4B	10.08B	1.27B	8.45B	19.42B
Change In Net Working Capital	-1.41B	-2.14B	7.9B	279M	-6.84B
Net Debt Issued / Repaid	-12.2M	-171M	359M	-1.3B	-948M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	14.16	12.1	11.16	10.92	13.14
Return on Total Capital	18.7	16.72	15.54	14.73	17.66
Return On Equity %	24.86	21.44	19.41	18.35	21.76
Return on Common Equity	25.95	22.51	20.13	18.7	22.14
Margin Analysis
Gross Profit Margin %	52.8	53.22	44.48	42.17	51.04
SG&A Margin	16.89	15.94	13.43	13.24	15.92
EBITDA Margin %	21.17	22.61	18.47	16.63	21.21
EBITA Margin %	19.54	20.69	16.81	15.12	19.46
EBIT Margin %	19.33	20.4	16.52	14.84	19.21
Income From Continuing Operations Margin %	15.38	15.44	12.16	10.92	14.11
Net Income Margin %	15.3	15.51	12.17	10.79	13.97
Net Avail. For Common Margin %	15.3	15.51	12.17	10.79	13.97
Normalized Net Income Margin	12.95	12.79	10.08	8.88	11.73
Levered Free Cash Flow Margin	9.85	13.5	1.02	6.91	15.42
Unlevered Free Cash Flow Margin	10.14	13.82	1.28	7.16	15.68
Asset Turnover
Asset Turnover	1.17	0.95	1.08	1.18	1.09
Fixed Assets Turnover	5.4	4.44	5.33	5.38	4.85
Receivables Turnover (Average Receivables)	6.37	5.68	6.85	7.6	7.4
Inventory Turnover (Average Inventory)	3.69	3.15	3.76	3.89	3.75
Short Term Liquidity
Current Ratio	2.33	1.44	1.73	1.89	2.09
Quick Ratio	1.62	0.83	0.88	1.02	1.49
Operating Cash Flow to Current Liabilities	0.79	0.57	0.41	0.65	0.97
Days Sales Outstanding (Average Receivables)	57.48	64.31	53.25	48.03	49.49
Days Outstanding Inventory (Average Inventory)	99.08	115.75	97.05	93.94	97.56
Average Days Payable Outstanding	63.97	79.94	62.86	55.52	71.49
Cash Conversion Cycle (Average Days)	92.6	100.12	87.44	86.45	75.56
Long Term Solvency
Total Debt/Equity	6.16	5.67	6.3	5.25	4.44
Total Debt / Total Capital	5.8	5.37	5.92	4.98	4.25
LT Debt/Equity	2.32	1.6	1.48	2.36	2.25
Long-Term Debt / Total Capital	2.18	1.51	1.39	2.24	2.15
Total Liabilities / Total Assets	28.53	33.94	30.61	29.26	28.81
EBIT / Interest Expense	41.97	39.97	38.94	36.75	46.46
EBITDA / Interest Expense	46.88	45.24	44.5	42.28	52.61
(EBITDA - Capex) / Interest Expense	32.98	35.73	35.59	31.67	41.69
Total Debt / EBITDA	0.18	0.2	0.22	0.19	0.14
Net Debt / EBITDA	-0.72	-0.17	-0.06	-0.23	-0.75
Total Debt / (EBITDA - Capex)	0.26	0.25	0.28	0.26	0.18
Net Debt / (EBITDA - Capex)	-1.02	-0.22	-0.07	-0.31	-0.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.06	-0.02	36.04	18.93	4.95
Gross Profit, 1 Yr. Growth %	11.59	0.77	14.09	12.77	27.01
EBITDA, 1 Yr. Growth %	12.47	6.8	11.1	7.07	33.9
EBITA, 1 Yr. Growth %	12.51	5.85	10.54	6.96	35.05
EBIT, 1 Yr. Growth %	12.66	5.52	10.11	6.84	35.86
Earnings From Cont. Operations, 1 Yr. Growth %	20.86	0.36	7.16	6.8	35.58
Net Income, 1 Yr. Growth %	20.71	1.32	6.75	5.44	35.82
Normalized Net Income, 1 Yr. Growth %	12.37	6.46	7.22	4.83	38.6
Diluted EPS Before Extra, 1 Yr. Growth %	20.71	1.23	6.79	5.39	35.76
Accounts Receivable, 1 Yr. Growth %	5.56	18.4	7.78	6.81	8.8
Inventory, 1 Yr. Growth %	-0.53	32.78	37.35	7.2	-22.13
Net Property, Plant and Equip., 1 Yr. Growth %	34	12.17	14.19	21.35	12.29
Total Assets, 1 Yr. Growth %	10.5	35.11	7.76	10.61	15
Tangible Book Value, 1 Yr. Growth %	8.97	-33.52	32.1	24.31	28.19
Common Equity, 1 Yr. Growth %	7.41	25.53	14.5	12.63	16.57
Cash From Operations, 1 Yr. Growth %	51.47	8.8	-31.37	63.03	74.89
Capital Expenditures, 1 Yr. Growth %	77.94	-24.27	5.93	34.85	10.56
Levered Free Cash Flow, 1 Yr. Growth %	32.38	37.02	-89.73	706.07	134.32
Unlevered Free Cash Flow, 1 Yr. Growth %	32.28	36.28	-87.36	563.04	129.85
Dividend Per Share, 1 Yr. Growth %	7.69	21.43	17.65	10	45.45
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.55	1.51	16.62	27.2	11.72
Gross Profit, 2 Yr. CAGR %	10.58	6.04	7.03	13.43	19.68
EBITDA, 2 Yr. CAGR %	7.34	9.6	8.93	9.07	19.74
EBITA, 2 Yr. CAGR %	7.17	9.13	8.17	8.74	20.19
EBIT, 2 Yr. CAGR %	7.29	9.03	7.79	8.46	20.48
Earnings From Cont. Operations, 2 Yr. CAGR %	7.77	10.14	3.71	6.98	20.33
Net Income, 2 Yr. CAGR %	7.71	10.59	4	6.09	19.67
Normalized Net Income, 2 Yr. CAGR %	6.54	5.32	6.84	6.02	20.54
Diluted EPS Before Extra, 2 Yr. CAGR %	7.7	10.54	3.97	6.09	19.61
Accounts Receivable, 2 Yr. CAGR %	9.07	11.8	12.97	7.29	7.8
Inventory, 2 Yr. CAGR %	7.5	14.92	35.04	21.34	-8.64
Net Property, Plant and Equip., 2 Yr. CAGR %	22.59	22.6	13.18	17.72	16.74
Total Assets, 2 Yr. CAGR %	12.06	22.19	20.66	9.17	12.78
Tangible Book Value, 2 Yr. CAGR %	13.92	-14.89	-6.29	28.15	26.24
Common Equity, 2 Yr. CAGR %	11.65	16.12	19.88	13.56	14.58
Cash From Operations, 2 Yr. CAGR %	26.75	28.37	-13.59	5.78	68.86
Capital Expenditures, 2 Yr. CAGR %	62.53	16.08	-10.43	19.52	22.1
Levered Free Cash Flow, 2 Yr. CAGR %	23.25	34.68	-62.49	-9.03	334.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	23.77	34.27	-58.5	-8.46	290.38
Dividend Per Share, 2 Yr. CAGR %	8.01	14.35	19.52	13.76	26.49
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.1	6.26	11.91	17.39	19.3
Gross Profit, 3 Yr. CAGR %	9.43	7.21	8.53	8.91	17.79
EBITDA, 3 Yr. CAGR %	6.85	7.16	10.1	8.31	16.79
EBITA, 3 Yr. CAGR %	6.85	6.73	9.6	7.76	16.88
EBIT, 3 Yr. CAGR %	6.88	6.7	9.39	7.47	16.92
Earnings From Cont. Operations, 3 Yr. CAGR %	9.13	5.24	9.13	4.73	15.77
Net Income, 3 Yr. CAGR %	9.09	5.54	9.3	4.48	15.2
Normalized Net Income, 3 Yr. CAGR %	6.91	3.87	5.95	6.17	15.93
Diluted EPS Before Extra, 3 Yr. CAGR %	9.42	5.5	9.28	4.44	15.18
Accounts Receivable, 3 Yr. CAGR %	13.37	12.1	10.44	10.88	7.79
Inventory, 3 Yr. CAGR %	8.84	15.34	21.96	25.04	4.66
Net Property, Plant and Equip., 3 Yr. CAGR %	18.23	19.01	19.73	15.84	15.88
Total Assets, 3 Yr. CAGR %	11.04	19.27	17.18	17.21	11.08
Tangible Book Value, 3 Yr. CAGR %	9.68	-4.8	-1.46	2.97	28.16
Common Equity, 3 Yr. CAGR %	8.68	16.1	15.57	17.41	14.55
Cash From Operations, 3 Yr. CAGR %	17.25	20.46	4.19	6.77	25.08
Capital Expenditures, 3 Yr. CAGR %	51.98	26	12.6	2.66	16.46
Levered Free Cash Flow, 3 Yr. CAGR %	6.55	27.68	-42.89	4.28	24.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.06	27.81	-38.92	4.53	24.42
Dividend Per Share, 3 Yr. CAGR %	13.8	12.31	15.44	16.26	23.47
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.53	6.35	12.05	14.19	11.84
Gross Profit, 5 Yr. CAGR %	12.31	7.1	8.46	9.58	12.86
EBITDA, 5 Yr. CAGR %	14.86	7.04	7.68	7.92	13.86
EBITA, 5 Yr. CAGR %	15.94	6.91	7.37	7.53	13.72
EBIT, 5 Yr. CAGR %	16.43	6.66	7.25	7.4	13.7
Earnings From Cont. Operations, 5 Yr. CAGR %	16.92	6.89	6.93	5.93	13.48
Net Income, 5 Yr. CAGR %	16.85	7.1	7.02	5.76	13.33
Normalized Net Income, 5 Yr. CAGR %	17.74	5.68	5.28	4.72	11.56
Diluted EPS Before Extra, 5 Yr. CAGR %	17.07	7.28	7.21	5.73	13.3
Accounts Receivable, 5 Yr. CAGR %	14.96	13.79	13.21	10.15	9.38
Inventory, 5 Yr. CAGR %	7.71	14.49	18.65	17.7	8.65
Net Property, Plant and Equip., 5 Yr. CAGR %	7	13.7	16.18	18.49	18.52
Total Assets, 5 Yr. CAGR %	14.54	18.88	14.79	15.12	15.4
Tangible Book Value, 5 Yr. CAGR %	15.28	3.02	2.99	7.22	8.81
Common Equity, 5 Yr. CAGR %	14.43	16.22	13.03	15.08	15.18
Cash From Operations, 5 Yr. CAGR %	18.31	8.94	3.78	14.36	26.38
Capital Expenditures, 5 Yr. CAGR %	2.65	15.73	23.01	23.37	16.31
Levered Free Cash Flow, 5 Yr. CAGR %	52.77	19.53	-29.83	11.49	28.6
Unlevered Free Cash Flow, 5 Yr. CAGR %	50.39	19.6	-26.72	11.84	28.27
Dividend Per Share, 5 Yr. CAGR %	19.27	15.42	16.05	12.89	19.74